Generalized Anxiety Disorder: From Science to ArtHagop S. Akiskal, Elie Hantouche, Lewis L. Judd |
From inside the book
Results 1-3 of 28
Page 33
... Somatic symptom subscales GAD vs. normal controls Normal control • P < 0.0001 GAD patient 2 7 6 5 4 14 12 10 ᅡ 8 6 MALA Skin conductance ( microsiemens ) Mean Mean 3 2 1 2 1 Interbeat interval ( range , ms ) Skin conductance ( number ...
... Somatic symptom subscales GAD vs. normal controls Normal control • P < 0.0001 GAD patient 2 7 6 5 4 14 12 10 ᅡ 8 6 MALA Skin conductance ( microsiemens ) Mean Mean 3 2 1 2 1 Interbeat interval ( range , ms ) Skin conductance ( number ...
Page 35
... Somatic symptoms 10 1000 10 10 9 900 d 9 9 8 800 8 700 Milliseconds 600 500 400 300 2 200 1 100 0 0 SC IBI Microvolts Microvolts 8 7 2 S / T Baseline Stroop 1 0 0 FEMG GEMG Somatic measures Fig . 3. Effects of stress on somatic symptoms ...
... Somatic symptoms 10 1000 10 10 9 900 d 9 9 8 800 8 700 Milliseconds 600 500 400 300 2 200 1 100 0 0 SC IBI Microvolts Microvolts 8 7 2 S / T Baseline Stroop 1 0 0 FEMG GEMG Somatic measures Fig . 3. Effects of stress on somatic symptoms ...
Page 37
... somatic symptoms . Since alprazolam also reduced their physiological states , the pa- tients ' self - reports were synchronous with their bodily functions . Imipramine also led to a reduc- tion in anxiety , first reducing psychic symptoms ...
... somatic symptoms . Since alprazolam also reduced their physiological states , the pa- tients ' self - reports were synchronous with their bodily functions . Imipramine also led to a reduc- tion in anxiety , first reducing psychic symptoms ...
Contents
H S Akiskal L L Judd | 2 |
Comorbidity as a fundamental feature of 6 L L Judd R C Kessler M P Paulus | 12 |
On the one aspect of generalized anxiety 30 V Davtian | 32 |
Copyright | |
6 other sections not shown
Common terms and phrases
Acta action activity agents agonists animal antidepressants anxiety disorder anxiolytic anxious appear Arch Gen Psychiatry associated BARLOW behavior benzodiazepine buspirone changes chronic Clin clinical cognitive comorbid compared comparison criteria dependence diagnostic disturbance drug early effects efficacy emotional et al expectations experience factors fear function GAD patients genetic half-life heart human hydroxyzine increased individuals interview less levels lifetime long-term major depression measures medication ment mental months mood nature object observed onset panic disorder patients personality personality disorders phobia physiological placebo population present Press prevalence problems processes Psychiatry psychological psychopathology receptor reduced References relationship reported response risk score severity showed sleep social somatic specific stress subjects suggest symptoms syndrome Table temperament tension term therapy tion traits treat treatment trial variables weeks withdrawal worry York